Sanofi goes oral route in Recludix deal to develop tailored I&I drugs

Sanofi goes oral route in Recludix deal to develop tailored I&I drugs

Submitted by admin on July 21, 2023 - 10:12am
Source: 
Medical Marketing and Media
News Tags: 
Sanofi
Recludix Pharma
inflammatory diseases
drug development
Headline: 
Sanofi goes oral route in Recludix deal to develop tailored I&I drugs
snippet: 

Sanofi inked a deal to co-develop and commercialize oral anti-inflammatory drugs resulting from Recludix Pharma’s STAT6 platform technology.

Do Not Allow Advertisers to Use My Personal information